Corey Meadows

Title: Corey Meadows: Innovator in Isoprenoid Research

Introduction

Corey Meadows is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of isoprenoid research. His innovative work has led to the development of a patented technology that has the potential to impact various applications in the industry.

Latest Patents

Corey Meadows holds a patent for "Host cells and methods for reducing isoprenoid precursors and isoprenoids by geranylgeranyl reductase." This invention provides a genetically modified host cell capable of reducing one or more isoprenoids or their precursors. The genetically modified host cell comprises one or more geranylgeranyl reductases (GGRs) or polypeptides with at least 70% identity to an amino acid sequence of a GGR. The polypeptide exhibits enzymatic activity for catalyzing GGR-catalyzed reactions and reducing one or more prenyl alcohols or prenyl pyrophosphates. This patent represents a significant advancement in the field of metabolic engineering.

Career Highlights

Corey Meadows is affiliated with the University of California, where he conducts his research and development activities. His work focuses on genetic modifications that enhance the production of valuable compounds through biotechnological processes. With 1 patent to his name, he has established himself as a key figure in his area of expertise.

Collaborations

Corey has collaborated with notable colleagues such as Brett Garabedian and Florence Mingardon. Their combined efforts contribute to the advancement of research in the field of isoprenoid production and metabolic engineering.

Conclusion

Corey Meadows is an innovative inventor whose work in isoprenoid research has the potential to transform biotechnological applications. His patented technology showcases the importance of genetic modifications in enhancing production processes.